Suppr超能文献

[脂质代谢与脂肪生成:稳定同位素的应用]

[Lipid metabolism and lipogenesis: application of stable isotopes].

作者信息

Martínez J A, Martí A

机构信息

Dpto. Fisiología y Nutrición, Universidad de Navarra.

出版信息

Rev Med Univ Navarra. 1998 Apr-Jun;42(2):91-8.

Abstract

Fat metabolism is regulated by several neuroendocrine and nutritional factors, which affect equilibrium between lipogenesis and lipolysis. Lipid utilization and fate in the organism can be assessed by in vivo and in vitro methods by measuring the rate of the different metabolic pathways (dynamic aspects), but also the net balance which may lead to fat accumulation or loss (static aspects). The quantitation of synthesis and breakdown reactions can be performed by using different tracers such as radioactive and stable isotopes. Fatty acid synthesis can be independently measured by the intravenous infusion of 13C acetate and application of the MIDA technique. In brief, this method uses probability analysis to measure the synthesis of biological polymers. It is based on the mathematical principle that the labeling pattern of a polymer synthesized from a stable-isotopically labeled precursor will conform to a predicted binomial or multinomial expansion. Thus, the isotopic enrichment of the precursor pool is calculated from measurements on the product alone. In the case of fatty acid synthesis, the proportions of excess (above natural background abundance) of single-labeled and double labeled (EM1 and EM2 species respectively) are a function of the probability (p) that the precursor subunits were isotopically labeled. Using this value of P for the isotopic enrichment of the acetylCoA pool, the theoretical 13C enrichment in the fatty acid if 100% were newly formed from this acetate pool is calculated. The actual isotopic enrichment is measured by gas chromatography-mass spectrometry (GCMS). This value divided by the theoretical maximum value equals the fraction of the fatty acid that is newly formed (f). The value for f represents dilution of de novo synthesized fatty acid by non-de novo sources. This method requires that newly synthesized (labeled) and preformed (unlabeled) mix in the liver and communicate with plasma VLDL over the period of the isotope infusion. It also assumes that the major de novo fatty acid is only a single fatty acid, with minor elongation and/or desaturation processes. Finally, the infused isotopic acetate should have no physiologically important effect. This methodology can be applied to assess lipogenesis in very different nutritional and physiopathological conditions such as diabetes, AIDS, obesity, etc.

摘要

脂肪代谢受多种神经内分泌和营养因素调节,这些因素影响脂肪生成与脂肪分解之间的平衡。机体中脂质的利用和归宿可通过体内和体外方法,通过测量不同代谢途径的速率(动态方面)来评估,也可通过测量可能导致脂肪积累或减少的净平衡(静态方面)来评估。合成和分解反应的定量可通过使用不同的示踪剂来进行,如放射性同位素和稳定同位素。脂肪酸合成可通过静脉输注13C醋酸盐并应用MIDA技术独立测量。简而言之,该方法使用概率分析来测量生物聚合物的合成。它基于这样一个数学原理,即由稳定同位素标记的前体合成的聚合物的标记模式将符合预测的二项式或多项式展开。因此,前体池的同位素富集仅根据对产物的测量来计算。在脂肪酸合成的情况下,单标记和双标记(分别为EM1和EM2物种)的过量(高于自然本底丰度)比例是前体亚基被同位素标记的概率(p)的函数。利用该P值计算乙酰辅酶A池的同位素富集,计算如果100%的脂肪酸由该醋酸盐池新形成时脂肪酸中理论上的13C富集。实际的同位素富集通过气相色谱-质谱联用(GCMS)测量。该值除以理论最大值等于新形成的脂肪酸的比例(f)。f值代表从头合成的脂肪酸被非从头合成来源稀释的程度。该方法要求新合成的(标记的)和预先形成的(未标记的)在肝脏中混合,并在同位素输注期间与血浆极低密度脂蛋白(VLDL)进行交换。它还假设主要的从头脂肪酸只是单一脂肪酸,只有少量的延长和/或去饱和过程。最后,输注的同位素醋酸盐不应有重要的生理作用。这种方法可应用于评估在非常不同的营养和生理病理条件下,如糖尿病、艾滋病、肥胖症等中的脂肪生成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验